206 related articles for article (PubMed ID: 38556548)
1. Transcriptome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder.
Lee MH; Lee B; Park SE; Yang GE; Cheon S; Lee DH; Kang S; Sun YJ; Kim Y; Jung DS; Kim W; Kang J; Kim YR; Choi JW
Exp Mol Med; 2024 Apr; 56(4):904-921. PubMed ID: 38556548
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Barker RG; Wyckelsma VL; Xu H; Murphy RM
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
[TBL] [Abstract][Full Text] [Related]
4. Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse Model.
Hong M; Han IH; Choi I; Cha N; Kim W; Kim SK; Bae H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804803
[TBL] [Abstract][Full Text] [Related]
5. L-Lysine suppresses myofibrillar protein degradation and autophagy in skeletal muscles of senescence-accelerated mouse prone 8.
Sato T; Ito Y; Nagasawa T
Biogerontology; 2017 Feb; 18(1):85-95. PubMed ID: 27752791
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial hydrogen sulfide supplementation improves health in the
Ellwood RA; Hewitt JE; Torregrossa R; Philp AM; Hardee JP; Hughes S; van de Klashorst D; Gharahdaghi N; Anupom T; Slade L; Deane CS; Cooke M; Etheridge T; Piasecki M; Antebi A; Lynch GS; Philp A; Vanapalli SA; Whiteman M; Szewczyk NJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627403
[TBL] [Abstract][Full Text] [Related]
7. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
[TBL] [Abstract][Full Text] [Related]
8. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
10. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
11. PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy.
Ieronimakis N; Hays A; Prasad A; Janebodin K; Duffield JS; Reyes M
J Pathol; 2016 Dec; 240(4):410-424. PubMed ID: 27569721
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
[TBL] [Abstract][Full Text] [Related]
13. Platelet-Derived Growth Factor BB Influences Muscle Regeneration in Duchenne Muscle Dystrophy.
Piñol-Jurado P; Gallardo E; de Luna N; Suárez-Calvet X; Sánchez-Riera C; Fernández-Simón E; Gomis C; Illa I; Díaz-Manera J
Am J Pathol; 2017 Aug; 187(8):1814-1827. PubMed ID: 28618254
[TBL] [Abstract][Full Text] [Related]
14. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
15. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
Kumar A; Davuluri G; Silva RNE; Engelen MPKJ; Ten Have GAM; Prayson R; Deutz NEP; Dasarathy S
Hepatology; 2017 Jun; 65(6):2045-2058. PubMed ID: 28195332
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
[TBL] [Abstract][Full Text] [Related]
17. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice.
Liu N; Williams AH; Maxeiner JM; Bezprozvannaya S; Shelton JM; Richardson JA; Bassel-Duby R; Olson EN
J Clin Invest; 2012 Jun; 122(6):2054-65. PubMed ID: 22546853
[TBL] [Abstract][Full Text] [Related]
18. Understanding the process of fibrosis in Duchenne muscular dystrophy.
Kharraz Y; Guerra J; Pessina P; Serrano AL; Muñoz-Cánoves P
Biomed Res Int; 2014; 2014():965631. PubMed ID: 24877152
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
[TBL] [Abstract][Full Text] [Related]
20. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy.
Giovarelli M; Zecchini S; Catarinella G; Moscheni C; Sartori P; Barbieri C; Roux-Biejat P; Napoli A; Vantaggiato C; Cervia D; Perrotta C; Clementi E; Latella L; De Palma C
Pharmacol Res; 2021 Aug; 170():105751. PubMed ID: 34197911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
